The artificial intelligence (AI)-powered Ezra Flash reportedly enhances magnetic resonance imaging (MRI) and enables significant reductions in scan times and costs for full-body MRI.
Could 30-minute full-body magnetic resonance imaging (MRI) exams be a reality in the near future?
The Food and Drug Administration (FDA) has granted 510(k) clearance for Ezra Flash (Ezra), an artificial intelligence-enabled software that enhances the quality of images derived from a fast MRI protocol, according to Ezra, the developer of the software.
Emphasizing that Ezra Flash was trained on hundreds of thousands of MRI scans from a proprietary dataset, Ezra said the technology facilitates simultaneous image quality and scan time reduction to the point where it can reduce the costs of full-body MRI by 30 percent.
Here one can see imaging prior to (left) and after the use of Ezra Flash (right). (Images courtesy of Ezra.)
Noting that Ezra Flash has received FDA clearance for brain imaging, the company plans to utilize the technology to launch the first 30-minute full-body MRI.
Possibly facilitating proactive cancer detection for a broader patient base beyond those with established risk factors, the FDA clearance of Ezra Flash may represent the “ … beginning of a sea change in how medical imaging is used,” noted Daniel K. Sodickson, M.D., Ph.D., the chief of innovation and director of the Center for Advanced Imaging Innovation and research in the Department of Radiology at New York University (NYU).
“Ezra Flash will increase the accessibility of early-warning MRI, and Ezra’s dataset of repeated scans over time will help it to prevent false positives and ensure that the warnings it provides are appropriate and accurate,” emphasized Dr. Sodickson.
(Editor’s note: For related content, see “Can Alternative MRI Techniques Help Enhance CyberKnife Treatment Imaging?”)
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.